Doença de Moyamoya e anestesia com sevoflurano fora do centro cirúrgico: relato de caso
Moyamoya disease and sevoflurane anesthesia outside the surgery center: case report
Sheila Braga Machado; Florentino Fernandes Mendes; Adriana de Campos Angelini
Resumo
Palavras-chave
Abstract
Keywords
Referências
Fukui M, Kono S, Sueishi K. Moyamoya disease. Neuropathology. 2000;20:S61-64.
Franco CM, Fukujima MM, de Oliveira RD. Moyamoya disease: Report of three cases in Brazilian patients. Arq Neuropsiquiatr. 1999;57:371-376.
Sumikawa K, Nagai H. Moyamoya disease and anesthesia. Anesthesiology. 1983;58:204-205.
Brown SC, Lam AM. Moyamoya disease: - a review of clinical experience and anaesthetic management. Can J Anaesth. 1987;34:71-75.
Newberg LA, Michenfelder JD. Cerebral protection by isoflurane during hypoxemia or ischemia. Anesthesiology. 1983;59:29-35.
Malan TP, DiNardo JA, Isner RJ. Cardiovascular effects of sevoflurane compared with those of isoflurane in volunteers. Anesthesiology. 1995;83:918-928.
Sarner JB, Levine M, Davis PJ. Clinical characteristics of sevoflurane in children: a comparison with halothane. Anesthesiology. 1995;82:38-46.
Lerman J, Davis PJ, Welborn LG. Induction, recovery, and safety characteristics of sevoflurane in children undergoing ambulatory surgery: a comparison with halothane. Anesthesiology. 1996;84:1332-1340.
Borja MM, Celemin RM, Rodríguez FG. El sevoflurano em neuroanestesia. Act Anest Reanym. 2000;10:159-162.
Wodey E, Pladys P, Copin C. Comparative hemodynamic depression of sevoflurane versus halothane in infants: an echocardiographic study. Anesthesiology. 1997;84:795-800.